Development of a septic shock experimental model oriented at training. Application in the training of depuration techniques in the management of severe sepsis;Desarrollo de un modelo experimental de shock séptico orientado a la formación. Aplicación en el entrenamiento de técnicas de depuración en el manejo de la sepsis grave

Medicina Intensiva

Volumn 35, Issue 2, 2011, Pages 84-91

  Herrera Gutierrez M E ^a   Seller Perez G ^a   García, G Quesada ^a   Granados, M M ^b   Dominguez J M ^b   Gomez Villamandos R J ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Animal research; Extracorporeal depuration; Septic shock

Indexed keywords

CARBON DIOXIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DOG; EARLY INTERVENTION; EXPERIMENTAL MODEL; EXTRACORPOREAL DEPURATION; FOLLOW UP; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HEMOFILTRATION; HIGH VOLUME HEMOFILTRATION; LUNG PRESSURE; MEAN ARTERIAL PRESSURE; MEDICAL EDUCATION; NONHUMAN; RESPIRATORY FUNCTION; SEPTIC SHOCK; SURVIVAL RATE; SYSTOLE; TONOMETRY; TREATMENT RESPONSE;

ANIMALS; DOGS; ENDOTOXEMIA; HEMODYNAMICS; HEMOFILTRATION; INFECTIOUS DISEASE MEDICINE; LIPOPOLYSACCHARIDES; MODELS, ANIMAL; SHOCK, SEPTIC;

EID: 79952699247     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2010.12.011     Document Type: Article

References (22)

1. Blanco J., Muriel-Bombín A., Sagredo V., Taboada F., Gandía F., Tamayo L. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicenter study. Critical Care. 2008, 12:R158. for the Grupo de Estudios y Análisis en Cuidados Intensivos (G.R.E.C.I.A.).
2. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345:1368-1377.
3. Tetta C., Cavaillon J.M., Schulze M., Ronco C., Ghezzi P.M., Camussi G., et al. Removal of cytokines and activated complement components in an experimental model of continuous plasmafiltration coupled with sorbent adsorption. Nephrol Dial Transplant. 1988, 13:1458-1464.
4. Rimmel T., Assadi A., Cattenoz M., Desebbe O., Lambert C., Boselli E., et al. High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant. 2009, 24:421-427.
5. Haase M., Silvester W., Uchino S., Goldsmith D., Davenport P., Tipping P., et al. A pilot study of high-adsorption hemofiltration in human septic shock. Int J Artif Organs. 2007, 30:108-117.
6. Lonnemann G., Bechstein M., Linnenweber S., Burg M., Koch K.M. Tumor necrosis factor-alpha during continuous highflux hemodialysis in sepsis with acute renal failure. Kidney Int. 1999, 72:S84-S87.
7. Herrera M.E., Seller G., Maynar J., Sánchez-Izquierdo J.A. Epidemiología del FRA en las UCI españolas: Estudio prospectivo multicéntrico FRAMI. Med Intensiva. 2006, 30:260-267. Grupo FRAMI.
8. Brivet F.G., Kleinknnecht D.J., Loirat P., Landais P.J. Acute renal failure in intensive care units. Causes, outcome, and pronostic factors of hospital mortality: A prospective, multicenter study. Crit Care Med. 1996, 24:192-198. the French Study Group on Acute Renal Failure.
9. Uchino S., Doig G., Bellomo R., Motimatsu H., Morgera S., Schetz M., et al. Diuretics and mortality in acute renal failure. Crit Care Med. 2004, 32:1669-1677. the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) investigators.
10. Maynar-Moliner J., Sánchez-Izquierdo-Riera J.A., Herrera-Gutiérrez M. Renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008, 359:1960.
11. Stein B., Pfenninger E., Griinert A., Schmitz J.E., Hudde M. Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med. 1990, 16:494-499.
12. Grootendorst A.F., Van Bommel E.E.H., Van der Hoven B., Van Leengoed L.A.M.G., Van Osta A.L.M. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med. 1992, 18:235-240.
13. Honore P.M., Jamez J., Wauthier M., Lee P.A., Dugernier T., Pirenne B., et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med. 2000, 28:3581-3587.
14. Bellomo R., Kellum J.A., Gandhi J., Pinsky M.R. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med. 2000, 161:1429-1436.
15. Ullrich R., Roeder G., Lorber C., Quezado Z., Kneifel W. Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology. 2001, 95:428-436.
16. Mink S.N., Jha P., Wang R., Yang J., Bose D., Jacobs H., et al. Effect of continuous arteriovenous hemofiltration combined with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology. 1995, 83:178-190.
17. Lee P., Weger G., Pryor R.W., Matson J.R. Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med. 1998, 26:730-737.
18. Yekebas E.F., Eisenberger C.F., Ohnesorge H., Saalmüller A., Elsner H.A., Engelhardt M., et al. Attenuation of sepsis-related immunoparalysis by continuous venovenous hemofiltration in experimental porcine pancreatitis. Crit Care Med. 2001, 29:1423-1430.
19. Rogiers P., Sun Q., Dimopoulos G., Tu Z., Pauwels D. Blood warming during hemofiltration can improve hemodynamics and outcome in ovine septic shock. Anesthesiology. 2006, 104:1216-1222.
20. Sykora R., Chvojka J., Krouzecky A., Radej J., Karvunidis T., Varnerova V. High versus standard-volume haemofiltration in hyperdynamic porcine peritonitis: effects beyond haemodynamics?. Intensive Care Med. 2009, 35:371-380.
21. Buras J.A., Holzmann B., Sitkovsky M. Animal models of sepsis: Setting the stage. Nat Rev Drug Discov. 2005, 4:854-865.
22. Dyson A., Singer M. Animal models of sepsis: Why does preclinical efficacy fail to translate to the clinical setting?. Crit Care Med. 2009, 37(Suppl):S30-S37.